返回 Agenda
Session Chair(s)
Rachel Couchenour, PHARMD, MBA
VP, Head of Medical Affairs
Travere Therapeutics, United States
Muriel Fay Siadak
Director, Scientific Partnerships
Onyx Pharmaceuticals, United States
Learning Objective : At the conclusion of this session, participants should be able to: - Identify the points to evaluate when sizing and aligning a new or current field based MSL team - Describe MSL team resource needs & new models for resourcing based on therapeutic area need and industry standards - Discuss the impact of the evolving compliance environment on MSL team operational needs
Speaker(s)
Table 1 - MSL Team Resource Modeling
Muriel Fay Siadak
Onyx Pharmaceuticals, United States
Director, Scientific Partnerships
Table 2 - Compliance Impact on MSL Operations
Hilary Mandler, PHARMD
Supernus Pharmaceuticals, United States
Sr Dir, med strategy
Table 3 - Structure, Staffing & Team Sizing
Gary Tyson
Pharma Initiatives Consulting Group, United States
Principle
Table 4 - Evolving MSL Customer Segments - How do you find them & align your team to them?
Randy Miller, PHARMD, RPH
Boehringer Ingelheim Corporation, United States
Director, Field Based Medicine (MSL) Operations